Futura Medical plc.  

(Public, LON:FUM)   Watch this stock  
Find more results for FUM
53.20
-1.80 (-3.27%)
Mar 24 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 53.01 - 55.39
52 week 14.31 - 95.60
Open 55.00
Vol / Avg. 260,746.00/282,476.00
Mkt cap 64.56M*
P/E     -
Div/yield     -
EPS -0.05*
Shares 120.63M
Beta     -
Inst. own     -
*GBP

Key stats and ratios

Q2 (Jun '16) 2015
Net profit margin -2826.85% -17236.91%
Operating margin -3389.03% -20748.98%
EBITD margin - -20725.37%
Return on average assets -82.19% -64.14%
Return on average equity -97.45% -70.05%
Employees 8 -
CDP Score - -

Address

40 Surrey Technology Centre, Occam Road
GUILDFORD, GU2 7YG
United Kingdom - Map
+44-1483-685670 (Phone)
+44-1483-685671 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance

Description

Futura Medical plc is a United Kingdom-based pharmaceutical company that develops products for consumer healthcare. The Company is engaged in the research and development of pharmaceutical drugs and medical devices and the commercial exploitation. It is also engaged in transdermal delivery and has developed a transdermal technology, DermaSys for the absorption of active molecules through the skin. It specializes in sexual health and pain relief, and has approximately five products in its development pipeline, which include CSD500, MED2002, TPR100, TIB200 and SPR300. Its CSD500 product incorporates an erectogenic gel (known as Zanifil gel) to help men maintain a firmer erection during intercourse whilst wearing a condom. Its MED2002 is a gel applied directly to the penis for the treatment of male erectile dysfunction (ED). The Company's TPR100 is a gel to provide pain relief. Its SPR300 is a gel, which combines methyl salicylate and menthol with the DermaSys delivery system.

Officers and directors

James Henry Barder Chief Executive Officer, Executive Director
Age: 50
Derek Adrian Martin Finance Director, Company Secretary, Executive Director
Ken James Executive Director, Head of R&D
Age: 63
John Milne Clarke Non-Executive Chairman of the Board
Age: 65
Lisa Arnold Independent Non-Executive Director
Jonathan David Freeman Senior Independent Non-Executive Director